Literature DB >> 22265696

Aromatase inhibitors and musculoskeletal adverse events.

Pedro E R Liedke1, Paul E Goss.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22265696     DOI： 10.1016/S1470-2045(11)70345-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.

Authors:  Jennifer Y Sheng; Amanda L Blackford; Aditya Bardia; Raghunandan Venkat; Gedge Rosson; Jon Giles; Daniel F Hayes; Stacie C Jeter; Zhe Zhang; Jill Hayden; Anne Nguyen; Anna Maria Storniolo; Karineh Tarpinian; Norah Lynn Henry; Vered Stearns
Journal:  Breast Cancer Res Treat       Date:  2019-05-11       Impact factor: 4.872

2.  Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

Authors:  Vered Stearns; Judith-Anne W Chapman; Cynthia X Ma; Matthew J Ellis; James N Ingle; Kathleen I Pritchard; G Thomas Budd; Manuela Rabaglio; George W Sledge; Aurélie Le Maitre; Jessica Kundapur; Pedro E R Liedke; Lois E Shepherd; Paul E Goss
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.